Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Burning Rock Biotech (BNR) Investment Income: 2020-2024

Historic Investment Income for Burning Rock Biotech (BNR) over the last 5 years, with Dec 2024 value amounting to $477,000.

  • Burning Rock Biotech's Investment Income rose 57.62% to -$242,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$296,000, marking a year-over-year decrease of 6.47%. This contributed to the annual value of $477,000 for FY2024, which is 19.15% down from last year.
  • As of FY2024, Burning Rock Biotech's Investment Income stood at $477,000, which was down 19.15% from $590,000 recorded in FY2023.
  • In the past 5 years, Burning Rock Biotech's Investment Income ranged from a high of $6.0 million in FY2022 and a low of -$27.1 million during FY2020.
  • For the 3-year period, Burning Rock Biotech's Investment Income averaged around $2.4 million, with its median value being $590,000 (2023).
  • As far as peak fluctuations go, Burning Rock Biotech's Investment Income soared by 196.77% in 2022, and later tumbled by 90.16% in 2023.
  • Over the past 5 years, Burning Rock Biotech's Investment Income (MRY) stood at -$27.1 million in 2020, then soared by 77.15% to -$6.2 million in 2021, then surged by 196.77% to $6.0 million in 2022, then tumbled by 90.16% to $590,000 in 2023, then dropped by 19.15% to $477,000 in 2024.
  • Its Investment Income was $477,000 in FY2024, compared to $590,000 in FY2023 and $6.0 million in FY2022.